ProfileGDS4718 / 234329_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 7% 15% 8% 17% 18% 9% 19% 13% 14% 17% 16% 9% 16% 17% 19% 18% 12% 15% 14% 22% 16% 14% 16% 17% 14% 15% 16% 11% 17% 19% 20% 15% 15% 16% 16% 12% 20% 17% 12% 12% 18% 24% 19% 14% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.689517
GSM549102patient 115, normal, homogenized [OPG study]3.9644315
GSM549104patient 119, normal, homogenized [OPG study]3.700028
GSM549108patient 138, normal, homogenized [OPG study]4.064217
GSM549119patient 077, normal, homogenized [OPG study]4.0744218
GSM549133patient 032, cancer, homogenized [OPG study]3.721479
GSM549139patient 042, cancer, homogenized [OPG study]4.0863519
GSM549099patient 107, normal, homogenized [OPG study]3.9069313
GSM549109patient 139, normal, homogenized [OPG study]3.9676514
GSM549110patient 046, normal, homogenized [OPG study]4.0486617
GSM549114patient 063, normal, homogenized [OPG study]3.9863216
GSM549122patient 082, normal, homogenized [OPG study]3.76549
GSM549134patient 033, cancer, homogenized [OPG study]3.9845416
GSM549136patient 036, cancer, homogenized [OPG study]3.989517
GSM549140patient 044, cancer, homogenized [OPG study]4.0663919
GSM549111patient 047, normal, homogenized [OPG study]4.0281318
GSM549113patient 057, normal, homogenized [OPG study]3.827912
GSM549132patient 031, cancer, homogenized [OPG study]3.9643215
GSM549137patient 038, cancer, homogenized [OPG study]3.92114
GSM549142patient 047, cancer, homogenized [OPG study]4.2977722
GSM549100patient 110, normal, homogenized [OPG study]4.0164516
GSM549107patient 135, normal, homogenized [OPG study]3.895514
GSM549115patient 068, normal, homogenized [OPG study]3.9432616
GSM549116patient 072, normal, homogenized [OPG study]4.0280317
GSM549120patient 078, normal, homogenized [OPG study]3.931414
GSM549131patient 030, cancer, homogenized [OPG study]3.9340515
GSM549118patient 074, normal, homogenized [OPG study]4.0102616
GSM549129patient 027, cancer, homogenized [OPG study]3.8145311
GSM549123patient 088, normal, homogenized [OPG study]4.0209517
GSM549124patient 006, cancer, homogenized [OPG study]4.1491919
GSM549126patient 015, cancer, homogenized [OPG study]4.1207920
GSM549128patient 025, cancer, homogenized [OPG study]3.918915
GSM549103patient 117, normal, homogenized [OPG study]3.9926615
GSM549117patient 073, normal, homogenized [OPG study]3.9815916
GSM549138patient 041, cancer, homogenized [OPG study]3.9853216
GSM549141patient 045, cancer, homogenized [OPG study]3.7992912
GSM549130patient 028, cancer, homogenized [OPG study]4.1791820
GSM549101patient 111, normal, homogenized [OPG study]4.0378917
GSM549105patient 128, normal, homogenized [OPG study]3.8729412
GSM549106patient 134, normal, homogenized [OPG study]3.8197412
GSM549112patient 048, normal, homogenized [OPG study]4.0750418
GSM549125patient 011, cancer, homogenized [OPG study]4.3205124
GSM549127patient 024, cancer, homogenized [OPG study]4.0721119
GSM549135patient 035, cancer, homogenized [OPG study]3.8632914